Adheron Therapeutics, a privately held biotechnology company based in Berkeley, California, United States, announced that it has agreed to be ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE